Nitazoxanide for the empiric treatment of pediatric infectious diarrhea (Q34251544)

31 July 2017

Nitazoxanide for the empiric treatment of pediatric infectious diarrhea (English)

1 reference

31 July 2017

0 references

Jean-François Rossignol

1

1 reference

31 July 2017

Nicolas Lopez-Chegne

2

1 reference

31 July 2017

Luis Martin Julcamoro

3

1 reference

31 July 2017

Maria E Carrion

4

1 reference

31 July 2017

Matthew C Bardin

5

1 reference

31 July 2017

31 January 2012

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

31 July 2017

1 reference

31 July 2017

106

1 reference

31 July 2017

167-173

1 reference

31 July 2017

3

1 reference

Estimating child mortality due to diarrhoea in developing countries

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Global Illness and Deaths Caused by Rotavirus Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Etiology of diarrhea in young children in Denmark: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Prevalence and clinical characteristics of norovirus gastroenteritis among hospitalized children in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Epidemiology and clinical features of gastroenteritis in hospitalised children: prospective survey during a 2-year period in a Parisian hospital, France.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Nitazoxanide: a new thiazolide antiparasitic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Effect of Nitazoxanide in Persistent Diarrhea and Enteritis Associated With

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Systematic literature review of role of noroviruses in sporadic gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Diagnosis of Norovirus outbreaks by commercial ELISA or RT-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2011.11.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2011.11.007

1 reference

31 July 2017

1 reference